Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction

25 April 2024 (09:00 - 12:30)

Organised by:

Sign in to view the resources

Sign in to view the resources

About the speaker

Doctor Dimitrios Delialis

Alexandra University Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail

Discussants - Understanding cardiovascular risk development: novel mechanisms (2)

Presentation thumbnail

Effect of metabolic syndrome on mean platelet volume and relationship to extent of coronary artery disease.

Doctor E. Sdogkos (Veria, GR)

Abstract Slides

Presentation thumbnail

Unlocking the mystery. Exploring the relationship between PFO anatomical features and the right to left shunt size

Doctor D. Maritsa (London, GB)

Presentation thumbnail

Plasma galectin-3 as a novel biomarker to cardiac events in very high-risk atherosclerotic cardiovascular disease population: a prospective study in an upper-middle-income country

Mr F. Qhabibi (West Jakarta, ID)

Abstract Slides

Presentation thumbnail

Red cell distribution width - prognostic parameter that could be used in heart failure patients

Doctor A. Catana (Bucharest, RO)

Abstract Slides

Access the full session

Session thumbnail

Poster session 3 - Understanding cardiovascular risk development: novel mechanisms (2)

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

You may be interested in

Webinar

Biomarkers of clinical utility in cardiovascular disease

Congress Session

Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

Webinar

Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources